title: Hopes rise for new Alzheimer's drug after secondary analysis.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C550616:solanezumab